Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2025-12-28 @ 12:19 PM
Study NCT ID:
NCT01113957
Status:
COMPLETED
Last Update Posted:
2018-06-06
First Post:
2010-02-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer
Sponsor:
AbbVie (prior sponsor, Abbott)